Zota Health Care LImited

Zota Health Care LImited

Zota Health Care Limited has responded to the National Stock Exchange's query regarding a significant increase in trading volume, stating that the movement is market-driven and that the company has made all required disclosures.

Zota Health Care LImited

Zota Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.

Zota Health Care LImited

Zota Health Care Limited has informed the Exchange about Clarification regarding Increase in Volume

Zota Health Care LImited

Zota Health Care Limited has observed a significant increase in volume, prompting the exchange to write to the company for a response.

Zota Health Care LImited

Zota Health Care Limited has informed the Exchange about Davaindia Stores Update for Q2FY27, stating a total of 2840 stores as on 30-09-2026, with 1859 COCO stores and 981 FOFO stores. The company has slowed down store expansion in Q2FY27 but plans to resume rapid expansion from Q3FY27 onwards.

Zota Health Care LImited

Zota Health Care Limited has acquired 39,228 equity shares of its wholly-owned subsidiary, Davaindia Health Mart Limited, by subscribing to the right issue at Rs. 5075.00 per equity share.

Zota Health Care LImited

Zota Health Care Limited has acquired 21,00,000 equity shares of its wholly-owned subsidiary KMHP Ventures Limited through a right issue, with a cost of acquisition of Rs. 2,10,00,000.00/-.

Zota Health Care LImited

Zota Health Care Limited has acquired 20,20,000 equity shares of its wholly-owned subsidiary, Curexis Ventures Private Limited, through a right issue. The acquisition is expected to reduce the company's total outstanding debt and improve its overall net worth.

Zota Health Care LImited

Zota Health Care Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on September 28, 2026. The company has informed the Exchange regarding voting results. All resolutions set out in the notice of the AGM have been duly approved by the shareholders with requisite majority.

Zota Health Care LImited

Zota Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Zota Health Care LImited

Zota Health Care Limited held its 26th Annual General Meeting on September 28, 2026, where the company's financial statements for the year ended March 31, 2026, were adopted, and a final dividend of 10% was declared. The meeting also saw the appointment of new directors and the approval of related party transactions.

Zota Health Care LImited

Zota Health Care Limited has informed the Exchange about the tax deduction on dividend payout, as per the Income Tax Act, 2025, and the Finance Act, 2020, which requires the company to withhold tax at source from dividends paid to shareholders.

Zota Health Care LImited

Zota Health Care Limited has responded to a proxy advisory firm's recommendations against certain resolutions at its upcoming Annual General Meeting, clarifying the experience and qualifications of its promoter directors and the remuneration structure.

Zota Health Care LImited

Zota Health Care Limited has informed the Exchange regarding Cessation of Mrs Varshabahen Gaurang Mehta as Non- Executive Independent Director of the company w.e.f. September 09, 2026, upon completion of her tenure.

Zota Health Care LImited

Zota Health Care Limited has informed the Exchange about the publication of newspaper advertisements for its 26th Annual General Meeting (AGM), record date, and final dividend.

Zota Health Care LImited

Zota Health Care Limited has informed the Exchange about the publication of a newspaper advertisement for its 26th Annual General Meeting (AGM) scheduled on September 28, 2026, through video conferencing.

Zota Health Care LImited

Zota Health Care Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026. The Board of Directors has approved the Director's Report for the year ended March 31, 2026, and decided to hold the 26th AGM on September 28, 2026. The Board has also appointed Mr. Mahaveer Dhariwal as the Additional Director, to be designated as the Independent Director of the Company.

Zota Health Care LImited

Zota Health Care Limited has announced a record date of September 21, 2026, for the purpose of final dividend and annual general meeting.

Zota Health Care LImited

Zota Health Care Limited has informed the Exchange regarding the appointment of Mr. Mahaveer Dhariwal as the Additional Director to be designated as the Non-Executive Independent Director of the company, effective September 03, 2026. The company also announced the 26th Annual General Meeting to be held on September 28, 2026, and the appointment of Mr. Ranjit Binod Kejriwal as the Scrutinizer for the e-voting process.

Zota Health Care LImited

Zota Health Care Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026. The Board has approved the Director’s Report for the year ended March 31, 2026, Notice of the 26th Annual General Meeting (AGM), and appointment of Mr. Mahaveer Dhariwal as the Additional Director.